Dartmouth's therapy bot cuts depression symptoms by 51%
Dartmouth researchers just published the first clinical trial of a generative AI therapy chatbot, Therabot, showing participants experienced a 51% drop in depression symptoms and a 31% drop in anxiety. Patients trusted the bot almost like a human therapist, often reaching out during late-night crises. Why it matters: With 1,600 patients per provider in the U.S., clinically backed AI could bridge massive shortages, though researchers stress expert supervision remains essential.